NATR

Nature’s Sunshine’s second quarter was met with a significant negative market reaction following results that missed Wall Street’s revenue and non-GAAP profit expectations. Management attributed the quarter’s growth to strong digital channel expansion, particularly in North America and Asia Pacific, and highlighted a 26% increase in digital sales. CEO Ken Romanzi pointed to ongoing investments in digital tools, consultant engagement, and new customer acquisition as key drivers, while acknowledging regional weakness, especially the unexpected slowdown in China. Is now the time to buy NATR? Find out in our full research report (it’s free). Revenue: $117 million vs analyst estimates of $123.7 million (1.9% year-on-year growth, 5.4% miss) Adjusted EPS: $0.21 vs analyst expectations of $0.27 (22.2% miss) Adjusted EBITDA: $11.33 million vs analyst estimates of $12.19 million (9.7% margin, 7.1% miss) The company dropped its revenue guidance for the full year to $495 million at the midpoint from $507.5 million, a 2.5% decrease EBITDA guidance for the full year is $50 million at the midpoint, below analyst estimates of $52.65 million Operating Margin: 4.7%, in line with the same quarter last year Market Capitalization: $272.9 million While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Susan Anderson (Canaccord Genuity) asked for more detail on North America’s core business performance and the Germany market launch. CEO Ken Romanzi acknowledged ongoing softness in the direct selling channel but highlighted plans for a comprehensive relaunch and gradual ramp-up in Germany as strategic priorities. Susan Anderson (Canaccord Genuity) inquired about product and brand drivers across regions. Romanzi explained that Synergy’s core products and new skincare offerings are fueling growth in Asia, while gut health products remain the top sellers in North America. Susan Anderson (Canaccord Genuity) questioned M&A strategy and criteria. Romanzi stated the company is targeting supplement businesses that can be integrated into its supply chain, with a preference for diversification by channel and geography, but will be selective to ensure earnings accretion and operational fit. Looking ahead, the StockStory team will be closely monitoring (1) the pace of digital and social commerce adoption, especially the conversion of new customers into recurring subscription buyers; (2) the impact of operational recovery efforts in China and the early performance of the Germany market; and (3) the effectiveness of leadership transitions in accelerating North American direct selling growth. The launch trajectory of new product lines and the ability to mitigate foreign exchange headwinds remain additional key signposts. Nature's Sunshine currently trades at $15.63, down from $20.34 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free for active Edge members). ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time. Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE. Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Image source: The Motley Fool. Thursday, Aug. 6, 2026, at 5 p.m. ET Chief Executive Officer-Ken Romanzi Chief Accounting Officer-Jon Lanoy General Counsel-Nate Brower Operator: Good afternoon everyone and thank you for participating in today's conference call for Nature's Sunshine financial results for the second quarter ended June 30, 2026. Joining us today are Nature's Sunshine's Chief Executive Officer; Ken Romanzi, Chief Accounting Officer, Jon Lanoy and General Counsel, Nate Brower. Following their remarks, we'll open the call for analyst questions. Before we go further, I would like to turn the call over to Mr. Brower as he reads the company's safe harbor statement within the meaning of the Private Securities Litigation Reform Act of 1995 that provides important cautions regarding forward-looking statements. Nate, please go ahead. Nathan Brower: Thank you, Lindy. Good afternoon, and thanks for joining our conference call to discuss our second quarter 2026 financial results. I'd like to remind everyone that this call is available for replay via telephonic dial-in through August 20 and via a live webcast that will be posted in the Investor Relations portion of our website at ir.naturessunshine.com. The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause the results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release issued today and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today's date. And the company disclaims any duty to update the information provided herein. Now I would like to turn the call over to the CEO of Nature's Sunshine, Ken Romanzi. Ken? Kenneth Romanzi: Thank you, Nate, and good afternoon, everyone. Thank you for joining our second quarter earnings call. I'm pleased to report that we delivered a solid second quarter, growing sales 4% in constant currency reflecting continued momentum across our key strategic initiatives. Our sales growth was driven by nearly all our geographic regions, led by 5% growth in Asia Pacific, driven by strong consultant engagement, and in North America, where digital sales increased 26%, fueled by continued momentum with new and returning customers. Growth was supported by continued customer acquisition, expansion of our digital capabilities, increased adoption of our autoship subscription programs and solid consultant growth. Strong execution, disciplined cost management and ongoing productivity initiatives also drove further gross margin expansion. The second quarter marked the beginning of our investments and our Vision for Growth. That's our name for our strategic plan to accelerate our longer-term growth rates. These investments include continued expansion of our digital business, enhanced digital tools for our consultant base, deeper penetration of existing markets and expansion into new markets. We believe these investments, combined with our strong business model and disciplined execution, will lead to sustainable accelerated long-term growth. I will update you on the progress we have made in developing our Vision for Growth a bit later in the call, after our Chief Accounting Officer, Jon Lanoy, provides the details of our Q2 performance. Jon? Jonathan Lanoy: Thank you, Ken. Net sales in the second quarter were $117 million, representing our strongest second quarter in company history, this represents a 2% increase versus the year ago quarter or a 4% increase, excluding the impact of foreign exchange rates. We experienced growth in all key regions across the globe. Total Asia Pacific sales grew 1% year-over-year to $53 million or 5% growth on a constant currency basis. While strong, our growth in APAC was lower than we expected. On the one hand, we saw outstanding growth in Japan of 50%. On the other hand, we experienced weakness in China, down 20%, a reversal from its recent growth trend of over 30% over the past year due to a few operational issues. We believe these issues are short term in nature that we will work through in the second half of the year, but this does not shake our confidence in China's continued long-term growth potential. Excluding China, where we market the Nature's Sunshine brand, our Synergy Eagle system sales in APAC continued strong momentum, growing 11% versus last year. In North America, Q2 sales grew 3% year-over-year to $36 million bringing sales growth to 6% through the first half of the year. During the quarter, we continued to see strong growth in our digital business, increasing 26% year-over-year. Within digital, new customers were up 26% in the quarter with autoship accounting for 36% of total orders coming through our website. In addition, our social commerce business within digital continued to show strong growth up 177% with subscription autoship in this channel making up 60% of total social commerce revenue. Continued improvement in this metric is a leading indicator for future growth and profitability since the lifetime value of customers that utilize subscription autoship is more than 3x higher than other customers. We are also pleased with the continued strength in our European business, where Q2 sales increased 4%, versus the prior year to $26.7 million. These solid results were driven by 12% growth in Eastern Europe. This strength has been fueled by improved product availability as we work to ensure appropriate in-stock levels for our key products where we see high demand despite the continued unrest in the region. Turning to gross margin. We increased nearly 200 basis points to 73.7%, the highest gross margin we've seen in over 4 years. This improvement represents the benefit of our ongoing initiatives, which includes renegotiating logistics contracts, improved manufacturing efficiency, improved sourcing and more disciplined pricing. We expect gross margins are likely to average around the mid -- low to mid 73% range through the remainder of 2026. Volume incentives as a percentage of net sales were 30.6% compared to 29.9% versus a year ago, primarily due to changes in market mix. SG&A expenses during the second quarter were $44.9 million compared to $43.7 million a year ago. As a percentage of net sales, SG&A expenses were 38.4% for the second quarter compared to 38.1% a year ago. The growth in SG&A is a result of our investment to fuel our Vision for Growth. As discussed last quarter, we expect quarterly SG&A to continue in the range of $45 million to $47 million for the remainder of the year as we continue to ramp up these initiatives. Adjusted EBITDA, as defined in our earnings release, was $11.3 million, up nearly 1% as we begin to implement our strategic -- our planned strategic initiatives. Our balance sheet remains clean with cash and cash equivalents of $82.5 million and 0 debt. Net cash used by operating activities was $1.1 million compared to cash provided of $6.9 million in the prior year period. We repurchased 113,000 shares for approximately $2.5 million or $22.55 per share during the 6 months ended June 30, 2026, leaving $14.8 million remaining in our share repurchase program. Looking beyond share repurchases, our healthy capital allocation structure positions us well to continue our digital transformation and other strategic initiatives. Turning to our 2026 outlook. Due to recent changes in exchange rates and our slowdown in China, we are lowering our previous guidance to $490 million to $500 million in net sales from $500 million to $515 million or year-over-year growth of 2% to 4%, respectively. In addition, we are lowering our guidance for EBITDA to $48 million to $52 million from $50 million to $54 million. Overall, we believe the business is well positioned to capitalize on current opportunities in a growing market and remain very optimistic about our ability to continue to unlock substantial growth prospects that we see. The strategic initiatives we've been implementing are working, we are confident in our ability to continue to accelerate growth in sales, profitability and free cash flow. Now I'll turn the time back over to Ken for some further commentary. Kenneth Romanzi: Thank you, Jon. I'd like to publicly acknowledge Jon today for his terrific service in Nature's Sunshine, keeping our financial house in order as we operated this past quarter without a Chief Financial Officer. Jon's deep experience, leadership and strong relationships throughout our company allowed us to continue seamlessly after Shane Jones departure in June. As I hope you saw from our press release earlier today, we have appointed Ruth Perkins as Nature Sunshine's Chief Financial Officer. Ruth brings a wealth of financial leadership experience from blue-chip consumer product companies, such as Ford, Estée Lauder and PepsiCo. As the financial leader of Estée Lauder's entire $10 billion supply chain and head of PepsiCo's $26 billion North American beverage finance organization, Ruth will bring a tremendous amount of leadership to Nature's Sunshine as we scale our business to achieve our Vision for Growth. Ruth will be returning to our home state of Utah to join us effective September 1. We also announced earlier this week that we appointed Janine Weber as our new President of North America, effective August 10. Janine is a 25-year veteran of the direct selling industry, most recently as President of North America for LifeWave; and former Vice President of Sales North America and General Manager of Canada for Rodan + Fields. She was a key player that helped that company to $1 billion in sales, making it at the time, the #1 skin care company in the United States. Janine's leadership will be critical as we plan to reinvent our direct selling system in North America as part of our Vision for Growth. We have set long-term goals for our Vision for Growth to double the size of the company to $1 billion in sales and improve our EBITDA margin to 15% from its currently just north of 10%. There are 4 key growth drivers of our vision. They are: number one, continued digital channel expansion; two, geographic penetration and geographic expansion; three, superior marketing and product innovation; and lastly, four, mergers and acquisitions. Now we don't know when that might be, but we are on the lookout for accretive acquisition opportunities that would complement our portfolio and strategic objectives. Our first growth driver is to continue digital expansion. We could not be happier in the growth of our digital business which is on track to deliver $50 million in sales by the end of this year, just 5 years after launching it. Our Vision for Growth includes expanding the digital channels in the U.S. as well as evaluating opportunities outside the U.S. Our second growth driver is deeper geographic penetration and geographic expansion. What I mean by deeper penetration, I'll give you 2 examples. First, Japan, where we are largely a Tokyo-based business, but have recently opened up a base in the southern Japanese city of Fukuoka, which is driving tremendous growth with plans for another city -- another opening in another city in 2027. Secondly, in the United States, we are planning a complete reinvigoration of our direct selling system beginning in early 2027. While we're encouraged by our recent growth in digital channels in the U.S., our direct selling business has been under pressure for quite some time. However, we believe we can have a thriving direct-to-consumer digital business in addition to a growing and thriving direct selling business. We will share more of our plans for Nature's Sunshine in the U.S. in the near future, and we are very fortunate to have Janine Weber on board to help lead this effort. Regarding geographic expansion, our launch in Germany is underway earlier this year, and we have plans to open a new Asian country through our very strong Eagle's Synergy system that operates in Japan, Taiwan and Korea sometime in 2027 pending government approvals. And lastly, while we do sell some synergy in the United States, we're really treating it as a brand new country for expansion and the only one in the world where we will market both Nature's Sunshine and Synergy. These new countries will not be a significant portion of our business in the first year or 2 of expansion, but they are key components in our Vision for Growth to $1 billion in sales. Superior marketing and product innovation is our third key growth driver. This fall, we will be launching our new Nature's Sunshine consumer campaign called Live on the Bright Side, which beautifully expresses the brand's unique point of difference in this crowded marketplace of nutritional supplements. And our new product pipeline is full with several new product launches planned for this fall and early 2027. We will share these with you as we get closer to their launch dates. And last but not least, we plan to have M&A help us drive to our $1 billion goal. But as I mentioned earlier, we cannot predict when we will execute an acquisition, opportunities are crossing our desk daily, and we will make sure we evaluate and make the right choice. In summary, I could not be happier with the leadership team we have built at Nature's Sunshine and with all the opportunities to accelerate our growth. We believe the Sun has never shined brighter for Nature's Sunshine. We have our sights firmly set on $1 billion in sales. And with our Vision for Growth strategic plan, we believe we can achieve it. Thank you for your time and attention today and your continued support of Nature's Sunshine. I'd now like the call to turn back to the operator for questions. Operator? Operator: Ladies and gentlemen, we will now begin the question-and-answer session. [Operator Instructions] Your first question comes from the line of Susan Anderson with Canaccord Genuity. Susan Anderson: Nice job in the quarter. I wanted to ask maybe just how -- it sounds like the e-commerce business in North America continued to be strong. I guess -- maybe if you could give some more color just around the core business as well and how it performed? And then I think you guys also had a new launch in Germany. Just curious how that's going? Unknown Executive: You want to talk about core North America, just total North America. Kenneth Romanzi: North America, in total, North America was up -- which we have 2 numbers in mind, constant dollars, FX dollars about 3% in total North America. And our base direct selling business actually has been soft for several years. And so our digital business continues to perform really well. And a major juncture going forward is early next year, we'll be doing a whole new reinvigoration of our direct selling program, including new product, new compensation plan, new incentives and to really get what is still a very large core business growing as well. So continued digital expansion in the U.S. as well as a reinvigorated direct selling business and one of our largest countries is a big factor in improving our growth rates going forward. And regarding Germany, we just started in Germany. I think we mentioned last time, we'll do maybe $1 million in Germany this year. But that's where we have to start, right? It's -- these are not overnight successes. They grow over time. I know that over a 6-year period of time, Taiwan, we always look at Taiwan as an example, it went from $2 million to over $65 million in like a 5-year time frame. But it had to start at 0, then 1 then 2 and then it ramps up. So we're hoping that Germany can be tens of millions of dollars in size. It's the largest direct selling market in Europe. It's the largest supplement market in Europe. And so we are recruiting leaders as we speak. I think we're bringing on 150 consultants a month there right now. So it's -- it was just a big summit meeting in Berlin where 400 people paved their own way to learn about opportunities to join Nature's Sunshine as an independent consultant. So we are in the process of ramping up. Susan Anderson: Okay. Great. And then also, maybe if you could give some color just on the brands and products that drove the growth in each region. And I guess were there any standouts that you could call out? Kenneth Romanzi: So just to make sure everybody knows the detail in our brand makeup. So Nature's Sunshine is our brand in really North America, South America, Latin America as well as in Europe, Central and Eastern Europe, and China. Synergy is our brand in the rest of Asia, so Taiwan, Korea and Japan, as well as a little bit of Western Europe, which is a very, very small market for us. . So when we talk about APAC growth, most of the growth and most of the business is Synergy in those 3 countries; Taiwan, Korea and Japan. And Synergy is really I mean it's just been -- the APAC has been on a roll for a long time. That system was up 11% in the second quarter, continued strong growth across the countries. And it's really core products that have been around for a long time, they have a formula and they just keep replicating and duplicating that formula. And they have recently launched a skin care line, which is contributing to growth. And it's actually one of the product lines that they're really going to try to make a significant portion of their business going forward. It's right now small single digits as a percentage of total sales, but all of our country managers looking at their long-range plans recently, all of them are going to try to make it a significant piece of their sales, like 10%, 15%, even 20% of their sales over kind of a 3- to 5-year time frame. In the Nature's Sunshine, I can't really talk about any one specific part. We have so many products. So it's just the amalgamation of all of our products growing. Our biggest kind of product category in North America both in our direct selling and our digital direct-to-consumer business, most of -- our core business is really gut health, so it's really our gut health products and our gut health systems that are still the top sellers in those -- in the Nature's Sunshine areas. Susan Anderson: Okay. Great. [indiscernible] for me, when you mentioned M&A at the end there. I guess when you think about M&A, if you could maybe just give some thoughts around what type of acquisitions you would be looking to tack on? Do you want to stay within wellness supplements? Are there certain regions that you're looking at of the world? And then also, are you focused on DTC brands? Or how should we think about that? Kenneth Romanzi: Number -- so we're very, very clear. That's why we're going to be very, very selective. Number one, we are going to be in the supplement business. it will be something that we can absorb in our supply chain. That is a very critical factor. We have excess capacity in our manufacturing facility, so we will be looking at something that we can fold into our manufacturing facility so that we can generate all the self-manufacturing margin and the synergies that come along with that. We would prefer to be diversified in terms of our business mix, whether that be more direct-to-consumer, even retail or geography. While we love our direct selling business, we're not looking to add another one, but that's not out of the question. It really is the product and the product form and a category that we believe, and that have growth potential but first and foremost, one that we could easily complementary bring it into our system, and that's where we can make it the most accretive from an earnings standpoint and value creation standpoint. Supplements, self-manufacture, diversification of business and a product and a category that we think have growth potential. Operator: And I'm showing no further questions at this time. I would like to hand it back to the management for closing remarks. Kenneth Romanzi: We just want to thank everybody for their time and attention and continued support in Nature's Sunshine and look forward to reporting on our vision for our vision -- our progress on our Vision for Growth as we go forward. Thank you, Lindy. Operator: Thank you. And ladies and gentlemen, this concludes today's conference call. Thank you all for joining. You may now disconnect. Before you buy stock in Nature's Sunshine Products, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nature's Sunshine Products wasn’t one of them. The 10 stocks that made the cut are built for long-term growth and could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $421,943!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,382,819!* That performance is why people listen. With a track record of beating the S&P 500 by nearly 5x, Stock Advisor offers a distinct advantage. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built for the long haul. See the 10 stocks » *Stock Advisor returns as of August 14, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Nature's Sunshine (NATR) Q2 2026 Earnings Call Transcript was originally published by The Motley Fool

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Achieved 4% constant currency sales growth, marking the strongest second quarter in company history despite significant headwinds in the China market. North American digital sales grew 26%, driven by a 26% increase in new customer acquisition and rising adoption of high-value autoship programs. Gross margin expanded nearly 200 basis points to 73.7%, the highest level in over four years, attributed to logistics contract renegotiations and manufacturing efficiencies. Asia Pacific growth of 5% in constant currency was tempered by a 20% decline in China due to short-term operational issues, contrasting with 50% growth in Japan. The 'Vision for Growth' strategic plan was initiated to accelerate long-term growth through digital expansion, geographic penetration, and product innovation. Management emphasized the high lifetime value of subscription customers, noting that autoship users are more than 3x more valuable than standard customers. Eastern Europe demonstrated resilience with 12% growth, supported by strategic efforts to maintain product availability despite regional unrest. Lowered full-year 2026 net sales guidance to $490 million–$500 million and EBITDA to $48 million–$52 million due to foreign exchange shifts and the China slowdown. Established a long-term 'Vision for Growth' target to reach $1 billion in annual sales and expand EBITDA margins to 15% from the current level of approximately 10%. Planned a comprehensive 'reinventing' of the North American direct selling system for early 2027, including new compensation plans and product incentives. Anticipate quarterly SG&A expenses to remain in the $45 million to $47 million range for the rest of 2026 to fund strategic growth initiatives. Expect gross margins to average in the low-to-mid 73% range for the remainder of the year as productivity gains stabilize. Appointed Ruth Perkins as CFO and Janine Weber as President of North America to strengthen leadership for the $1 billion sales expansion goal. Identified China's 20% sales decline as a reversal of a 30% growth trend, though management characterizes the operational issues as short-term. Flagged market mix changes as the primary driver for a slight increase in volume incentives as a percentage of net sales to 30.6%. Maintained a debt-free balance sheet with $82.5 million in cash to support digital transformation and potential M&A activity. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. Management acknowledged the core direct selling business has been soft for several years, necessitating the 2027 reinvigoration plan. The Germany launch is in early stages with roughly 150 consultants joining monthly; management views it as a long-term ramp-up similar to Taiwan's historical growth. Growth in APAC is driven by the Synergy brand's core formulas and a new skin care line targeted to reach 10-20% of sales over 3-5 years. North American growth remains anchored in gut health systems across both digital and direct selling channels. M&A focus is strictly on the supplement business with a requirement that targets can be absorbed into existing manufacturing facilities to capture margin synergies. Management is seeking diversification in business mix (DTC or retail) and geography rather than simply adding another direct selling organization.

Interested in Nature's Sunshine Products, Inc.? Here are five stocks we like better. Record Q2 sales: Nature’s Sunshine reported $117 million in second-quarter net sales, up 2% year over year, while adjusted EBITDA rose nearly 1% to $11.3 million. Gross margin expanded nearly 200 basis points to 73.7%, its highest level in more than four years. Digital growth offset regional weakness: North American digital sales increased 26% and social-commerce sales surged 177%, while Japan and Europe also performed well. However, China sales fell 20% due to operational issues, weighing on Asia-Pacific results. 2026 outlook reduced: The company lowered its full-year sales forecast to $490 million-$500 million and adjusted EBITDA guidance to $48 million-$52 million, citing the China slowdown and currency changes. Management continues to target long-term expansion through digital channels, new markets, product innovation and acquisitions. Nature's Sunshine Products (NASDAQ:NATR) reported second-quarter net sales of $117 million, its strongest second quarter in company history, as digital growth in North America and continued momentum across much of Asia-Pacific and Europe supported results. Sales increased 2% from the prior-year quarter and rose 4% on a constant-currency basis. Chief Executive Officer Ken Romanzi said growth was driven by customer acquisition, expanded digital capabilities, autoship subscription adoption and consultant growth. He also said cost controls and productivity efforts contributed to further gross-margin expansion. → Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth Asia-Pacific sales increased 1% year over year to $53 million, or 5% on a constant-currency basis. Chief Accounting Officer Jon Lanoy said Japan delivered 50% growth, while China sales declined 20% following operational issues. China had previously grown more than 30% over the past year, he said. Lanoy characterized the China issues as short term and said management expects to address them during the second half of 2026. Excluding China, sales through the company's SynerG Eagle system in Asia-Pacific rose 11% from a year earlier. → 4 Oil and Gas ETF Plays as Prices Stay Sky-High North American sales grew 3% to $36 million in the second quarter, bringing first-half growth in the region to 6%. The company's digital business expanded 26%, with new customers also up 26%. Autoship represented 36% of orders placed through the company's website. Social commerce sales increased 177% year over year, according to Lanoy, while subscription autoship accounted for 60% of social-commerce revenue. He said the company views autoship participation as an indicator of future growth and profitability because the lifetime value of subscription customers is more than three times that of other customers. → Ulta's Growth Is Real, But So Are the Risks Romanzi said the company's core North American direct-selling business has been soft for several years, even as digital channels continue to expand. Nature's Sunshine plans to reinvigorate its U.S. direct-selling program in early 2027 through new products, a new compensation plan and incentives. European sales increased 4% to $26.7 million, helped by 12% growth in Eastern Europe. Lanoy said improved availability of key products supported the region despite continuing unrest there. Gross margin rose nearly 200 basis points to 73.7%, the highest level in more than four years. Lanoy attributed the improvement to renegotiated logistics contracts, manufacturing efficiencies, sourcing improvements and more disciplined pricing. The company expects gross margin to average in the low- to mid-73% range for the remainder of 2026. Volume incentives represented 30.6% of net sales, compared with 29.9% a year earlier, primarily because of market mix changes. Selling, general and administrative expenses increased to $44.9 million from $43.7 million and represented 38.4% of sales, versus 38.1% in the prior-year quarter. Management said the increase reflected investments behind its “Vision for Growth” strategy. Adjusted EBITDA was $11.3 million, up nearly 1% from a year earlier. Nature's Sunshine ended the quarter with $82.5 million in cash and cash equivalents and no debt. Net cash used in operating activities was $1.1 million, compared with $6.9 million of cash provided in the prior-year period. During the first six months of 2026, the company repurchased 113,000 shares for about $2.5 million, or $22.55 per share. It had $14.8 million remaining under its share repurchase program as of June 30. Nature's Sunshine lowered its 2026 outlook, citing recent exchange-rate changes and the slowdown in China. The company now expects full-year net sales of $490 million to $500 million, compared with prior guidance of $500 million to $515 million. The revised range implies year-over-year growth of 2% to 4%. The company also reduced its adjusted EBITDA outlook to $48 million to $52 million from its previous forecast of $50 million to $54 million. SG&A expense is expected to range from $45 million to $47 million per quarter for the rest of the year as strategic investments ramp up. Romanzi said the company's long-term “Vision for Growth” calls for doubling sales to $1 billion and increasing EBITDA margin to 15% from just over 10% currently. The strategy centers on four areas: Continued digital-channel expansion; Deeper geographic penetration and entry into new markets; Marketing and product innovation; and Mergers and acquisitions. The digital business is on track to generate $50 million in sales in 2026, five years after its launch, Romanzi said. The company is assessing opportunities to extend digital channels outside the U.S. Nature's Sunshine began its Germany launch earlier in 2026 and expects about $1 million in sales there this year. Romanzi said the company is targeting a potential $10 million business in Germany over time, noting that it is recruiting approximately 150 consultants per month and recently held a Berlin event attended by 400 people who paid their own way to learn about becoming independent consultants. Management also plans to enter a new Asian market through its SynerG system in 2027, subject to government approvals. The company intends to launch its “Live on the Bright Side” consumer campaign this fall and has several product introductions planned for the fall and early 2027. On acquisitions, Romanzi said the company is seeking potentially accretive opportunities in supplements that can be incorporated into its supply chain and manufacturing operations. He said management would favor opportunities that diversify its business mix through direct-to-consumer channels, retail or geography, while adding that the company is not actively seeking to acquire another direct-selling business. The company also announced that Ruth Perkins will become chief financial officer effective Sept. 1, following the June departure of former CFO Shane Jones. Perkins previously held financial leadership roles at Ford, The Estée Lauder Companies and PepsiCo. Janine Weber will join as president of North America effective Aug. 10, bringing 25 years of direct-selling industry experience, Romanzi said. Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers. The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Nature's Sunshine Products Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

This article first appeared on GuruFocus. Net Sales: $117 million in Q2 2026, a 2% increase year-over-year, or 4% growth on a constant currency basis. Asia Pacific Sales: $53 million, up 1% year-over-year (5% constant currency), with Japan up 50% and China down 20%. North America Sales: $36 million, up 3% year-over-year, with digital sales increasing 26%. Europe Sales: $26.7 million, up 4% year-over-year, driven by 12% growth in Eastern Europe. Gross Margin: 73.7%, up nearly 200 basis points, the highest in over four years. SG&A Expenses: $44.9 million, compared to $43.7 million a year ago; 38.4% of net sales. Adjusted EBITDA: $11.3 million, up nearly 1% year-over-year. Cash and Cash Equivalents: $82.5 million with zero debt. Net Cash Used by Operating Activities: $1.1 million, compared to cash provided of $6.9 million in the prior year period. Share Repurchases: 113,000 shares repurchased for approximately $2.5 million, or $22.55 per share, during the six months ended June 30, 2026. 2026 Net Sales Guidance: Lowered to $490 million to $500 million from $500 million to $515 million. 2026 EBITDA Guidance: Lowered to $48 million to $52 million from $50 million to $54 million. Warning! GuruFocus has detected 2 Warning Sign with NATR. Is NATR fairly valued? Test your thesis with our free DCF calculator. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Natures Sunshine Products Inc (NASDAQ:NATR) delivered its strongest second quarter in company history, with net sales of $117 million, up 4% in constant currency. Gross margin expanded nearly 200 basis points to 73.7%, the highest in over four years, driven by logistics renegotiations, manufacturing efficiency, and improved sourcing. Digital sales in North America surged 26% year-over-year, with new customers up 26% and auto-ship subscriptions accounting for 36% of website orders, indicating strong customer retention and lifetime value. The company is executing a clear 'Vision for Growth' strategy, targeting $1 billion in sales and a 15% EBITDA margin, with new leadership appointments (CFO Ruth Perkins, President of North America Janine Weber) to drive expansion. Geographic expansion is progressing, with Germany launched and a new Asian country planned for 2027, while Japan grew 50% and the Synergy system in APAC grew 11%. The balance sheet remains strong with $82.5 million in cash and zero debt, providing flexibility for strategic investments and M&A opportunities. Natures Sunshine Products Inc (NASDAQ:NATR) lowered its 2026 net sales guidance to $490-$500 million from $500-$515 million, and EBITDA guidance to $48-$52 million from $50-$54 million, due to FX changes and China weakness. China sales declined 20% in Q2, a sharp reversal from its prior 30% growth trend, due to operational issues that are expected to persist into the second half of the year. The core direct selling business in North America remains under pressure, with softness persisting for several years, despite overall regional growth driven by digital. SG&A expenses increased to 38.4% of net sales, up from 38.1%, reflecting higher investment costs that may pressure near-term profitability. Net cash used by operating activities was $1.1 million in Q2, a significant swing from $6.9 million provided in the prior year, indicating weaker cash flow generation. The company's growth is heavily reliant on the success of new initiatives (e.g., Germany, US direct selling reinvigoration) that are in early stages and may take years to contribute meaningfully. Q: Can you provide more color on the performance of the core direct selling business versus the e-commerce business in North America, and how the new launch in Germany is progressing?A: CEO Ken Romanzi noted that while total North America sales grew 3%, the base direct selling business has been soft for several years, but the digital business continues to perform very well. He highlighted a major upcoming initiative in early 2027 to reinvigorate the direct selling program with new products, compensation plans, and incentives. Regarding Germany, the launch is underway, with about 150 consultants being recruited per month and a recent summit in Berlin attracting 400 potential recruits. He compared this to Taiwan's growth trajectory, which grew from $2 million to over $65 million in five years, emphasizing that new markets take time to ramp up. Q: What are your thoughts on M&A, specifically regarding the type of acquisitions you would consider, target regions, and whether you are focused on DTC brands?A: CEO Ken Romanzi stated that the company is being very selective. Any acquisition must be in the supplement business and able to be absorbed into their existing supply chain to leverage excess manufacturing capacity and generate self-manufacturing margins. They prefer targets that diversify their business mix, whether by channel (DTC or retail) or geography. While they are not looking to add another direct selling company, it is not out of the question. The primary focus is on products and categories with growth potential that can be complementarily integrated into their system for maximum earnings accretion. Q: Can you provide more color on the brands and products that drove growth in each region? Were there any standout performers?A: CEO Ken Romanzi explained that the Nature's Sunshine brand operates in North America, Latin America, Europe, and China, while the Synergy brand operates in Taiwan, Korea, and Japan. APAC growth was driven by the Synergy system, which was up 11% in Q2, fueled by core products and a recently launched skincare line. While skincare is currently a small single-digit percentage of sales, country managers plan to grow it to 10%-20% of sales over the next 3-5 years. In North America, the top product category is gut health, which remains the best seller across both direct selling and digital channels. Q: Nice job on the quarter. I wanted to ask maybe just how -- it sounds like the e-commerce business in North America continued to be strong. I guess maybe if you could give some more color just around the core business as well and how it performed. And then I think you guys also had a new launch in Germany. Just curious how that's going. Thanks.A: (This question was answered in the first Q&A above, but for clarity) CEO Ken Romanzi reiterated that North America was up 3% in total, with the digital business performing really well. He emphasized that a major juncture going forward is the reinvigoration of the direct selling program in early next year. Regarding Germany, he confirmed the launch is underway, with expectations of around $1 million in sales this year, and highlighted the recruitment of 150 consultants per month and a successful summit in Berlin with 400 attendees. Q: This one's for you. You mentioned M&A at the end there. I guess when you think about M&A, if you could maybe just give some thoughts around what type of acquisitions you would be looking to tuck on. Do you want to stay within wellness supplements? Are there certain regions that you're looking at of the world? And then also, are you focused on DTC brands, or how should we think about that? Thanks.A: (This question was answered in the second Q&A above, but for clarity) CEO Ken Romanzi reiterated that the company is being very selective and will stay in the supplement business. The key criteria are that the acquisition can be absorbed into their supply chain to leverage excess manufacturing capacity, and it should diversify their business mix. They are open to DTC, retail, or geographic diversification, but the primary focus is on products and categories with growth potential that can be easily integrated for maximum earnings accretion. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $117.0 million compared to $114.8 million (up 4% in constant currency). Gross profit margin increased 194 basis points to 73.7% compared to 71.7%. GAAP net income attributable to common shareholders was $3.5 million, or $0.19 per diluted common share, compared to $5.3 million, or $0.28 per diluted common share. Adjusted EBITDA was $11.3 million compared to $11.3 million. Management Commentary "We delivered a solid quarter, with constant currency sales growth of 4% across nearly all of our geographic regions," said Ken Romanzi, CEO of Nature's Sunshine. "Results were led by 5% growth in Asia Pacific, driven by strong consultant engagement, and by North America, where digital sales increased 26%, fueled by continued momentum among new and returning customers. Growth was supported by continued customer acquisition, expansion of our digital capabilities, increased adoption of our auto-ship subscription programs, and solid consultant growth. Strong execution, disciplined cost management, and ongoing productivity initiatives also drove further gross margin expansion. "The second quarter marked the beginning of investments in our Vision for Growth, our plan to accelerate our longer-term growth rate including continued expansion of our digital business, enhanced digital tools for our consultant base, deeper penetration of existing markets, and expansion into new markets. We believe these investments, combined with our strong business model and disciplined execution, position us to deliver sustainable, accelerated long-term growth." Second Quarter 2026 Financial Results Net sales in the second quarter increased 2% to $117.0 million compared to $114.8 million in the same year-ago quarter. Excluding the impact from foreign exchange rates, net sales in the second quarter of 2026 increased 4% compared to the year-ago quarter. Gross profit margin in the second quarter increased to 73.7% compared to 71.7% in the year-ago quarter. The increase was driven by cost savings initiatives and market mix. Volume incentives as a percentage of net sales were 30.6% compared to 29.9% in the year-ago quarter. The increase was primarily due to timing of promotional incentives and market mix. Selling, general and administrative expenses ("SG&A") in the second quarter were $44.9 million compared to $43.7 million in the year‐ago quarter. The increase was primarily related to consultant events and variable selling expenses, partially offset by compensation costs. As a percentage of net sales, SG&A expenses were 38.4% for the second quarter of 2026 compared to 38.1% in the year-ago quarter. Operating income in the second quarter increased to $5.5 million, or 4.7% of net sales, compared to $4.3 million, or 3.7% of net sales, in the year-ago quarter. Other income (expense), net, in the second quarter of 2026 was $(0.1) million compared to $3.3 million in the second quarter of 2025. Other income (expense), net, primarily consisted of foreign exchange losses in Asia, partially offset by foreign exchange gains in Europe and Latin America that resulted from net changes in foreign currencies. The provision for income taxes was $1.8 million in the second quarter of 2026 compared to $2.0 million for the year-ago quarter. GAAP net income attributable to common shareholders decreased to $3.5 million, or $0.19 per diluted common share, compared to $5.3 million, or $0.28 per diluted common share, in the second quarter of 2025. As a result of the December 2025 purchase of noncontrolling interests, there was no net income attributable to NSP China for the second quarter of 2026, compared to $0.9 million, or $0.05 per diluted common share, for the second quarter of 2025. Adjusted EBITDA in the second quarter remained flat at $11.3 million compared to $11.3 million in the year-ago quarter. Adjusted EBITDA, which is a non-GAAP financial measure, is defined here as net income from continuing operations before taxes, depreciation, amortization, and other income (expense) adjusted to exclude share-based compensation expense and certain noted adjustments. A reconciliation of net income to adjusted EBITDA is provided in the attached financial tables. Balance Sheet and Cash Flow Net cash used by operating activities was $1.0 million for the six months ended June 30, 2026, compared to $6.9 million provided in the prior year period. Capital expenditures during the six months ended June 30, 2026, totaled $5.3 million compared to $2.5 million in the comparable period of 2025. During the six months ended June 30, 2026, the Company repurchased 113,000 shares at a total cost of $2.6 million or $22.55 per share. As of June 30, 2026, the Company had cash and cash equivalents of $82.5 million and zero debt. Outlook Reflecting the impact of a stronger U.S. dollar and recent softness in the China market, Nature's Sunshine now expects full year 2026 net sales to range between $490 to $500 million ($500 to $515 million prior). Adjusted EBITDA is now expected to range between $48 to $52 million ($50 to $54 million prior). Conference Call The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its second quarter of 2026 results. Date: Thursday, August 6, 2026Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time) Toll-free dial-in number: 1-800-717-1738 International dial-in number: 1-646-307-1865Conference ID: 39783 Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860. The conference call will be broadcast live and available for replay here and via the Events section of the Nature’s Sunshine website here. A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Thursday, August 20, 2026. Toll-free replay number: 1-844-512-2921International replay number: 1-412-317-6671Replay ID: 11139783 About Nature’s Sunshine Products Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected improvements in gross profit and gross margin. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following: extensive government regulations to which the Company’s products, business practices and manufacturing activities are subject, including, but not limited to, trade restrictions and export controls; registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets; legal challenges to the Company’s direct selling program or to the classification of its independent consultants; laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets; liabilities and obligations arising from improper activity by the Company’s independent consultants; product liability claims; impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act; the Company’s ability to attract and retain independent consultants; the loss of one or more key independent consultants who have a significant sales network; the effect of fluctuating foreign exchange rates; failure of the Company’s independent consultants to comply with advertising laws; changes to the Company’s independent consultants' compensation plans; geopolitical issues and conflicts, including changes to U.S. trade policy resulting in new or additional tariffs; negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company’s customers to purchase products; risks associated with the manufacturing of the Company’s products; supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand; failure to timely and effectively obtain shipments of products from our suppliers and contract manufacturers and deliver products to our independent consultants and customers; world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges; uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto; changes in tax laws, treaties or regulations, or their interpretation; failure to maintain an effective system of internal controls over financial reporting; cybersecurity threats and exposure to data loss; the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations; reliance on information technology infrastructure; and the sufficiency of trademarks and other intellectual property rights. These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q. All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release. Non-GAAP Financial Measures We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning non-GAAP net income, adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations. We believe that these non-GAAP measures provide investors with greater transparency to evaluate operational activities and financial results and facilitate consistent comparisons to the historical operating performance of prior periods. We utilize these non-GAAP measures of non-GAAP net income and adjusted EBITDA in the evaluation of our operations and believe that these measures are useful indicators of our operating performance and ability to fund our business. These non-GAAP financial measures should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income (loss) as an indicator of our operating performance. Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. We have included a reconciliation of net income, the most comparable GAAP measure, to adjusted EBITDA. We have also included a reconciliation of GAAP net income to non-GAAP net income and non-GAAP adjusted EPS, in the attached financial tables. Net sales in local currency removes, from net sales in U.S. dollars, the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries. This is accomplished by translating the current period's net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP. With respect to our adjusted EBITDA outlook for the full year 2026, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, we are unable to assess the probable significance of the unavailable information, which could have a material impact on our future GAAP financial results. Investor Relations: Gateway Group, Inc.Cody [email protected] * Other (income) expense, net is primarily comprised of foreign exchange (gains) losses, interest income, and interest expense.

Performance was driven by a 9% sales increase, led by North America's digital channel strategy and a global rise in active consultants. Digital business growth of 42% in North America was fueled by a 60% increase in new customer acquisition and high adoption of the subscription Autoship program. The China turnaround was attributed to the rapid implementation of the Autoship program, which grew from zero to 25% of revenue within one year. Gross margin expansion of 116 basis points resulted from renegotiated logistics contracts, improved manufacturing efficiency, and disciplined pricing strategies. Management highlighted that the lifetime value of subscription customers is more than three times higher than non-subscription customers, serving as a key profitability lever. European growth of 9% was achieved despite regional conflict, driven by improved product availability and economic stabilization in Eastern Europe. The company is leveraging excess manufacturing capacity to drive higher variable margins as volume increases across its global footprint. Management reiterated 2026 net sales guidance of $500 million to $515 million, representing 4% to 7% year-over-year growth. Adjusted EBITDA growth is expected to temporarily slow in Q2 and Q3 due to planned investments in technology infrastructure and geographic expansion. The company plans to enter Germany in 2026, marking its largest new market entry since 2016 and its first major push into Europe's largest supplement market. A long-term strategic goal was set to double annual sales to $1 billion while expanding EBITDA margins to 15% through scale and digital mix shift. Guidance incorporates a cautious stance regarding potential inflationary impacts and consumer demand shifts stemming from geopolitical tensions in Iran. Inventory levels are expected to increase moderately throughout 2026 to ensure product availability and meet strong consumer demand. The company maintains a debt-free balance sheet with $87.6 million in cash, positioning it to pursue accretive bolt-on acquisitions. A new Chief Technology Officer was appointed to lead the transition of the legacy Oracle ERP system and integrate AI into digital operations. SG&A expenses are projected to rise to a range of $45 million to $47 million per quarter for the remainder of the year as strategic initiatives ramp up. Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management identified three specific drivers: one point from gross margin scale, two points from lower volume incentives via digital shift, and two points from SG&A leverage. The digital business is more profitable because it requires lower commission payments compared to traditional consultant channels. The CTO will address the upcoming end-of-life for the current Oracle ERP system within the next five to six years. Focus areas include driving digital growth through AI and enhancing mobile tools that allow consultants to manage their entire business via smartphone. The company is preparing for its first-ever pan-Asian launch, introducing a unified product and formulation simultaneously across Korea, Japan, and Taiwan. Management declined to provide specific product details ahead of the launch but emphasized the use of a new 'Asia sales system' to leverage regional scale. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.